Glaucoma
Journal Club
Feed
Library
More
8,970
articles
·
updated 51m ago
Library
61 articles
Chapter 35
Neuroprotection and Other Investigational Drugs
Neuroprotective agents, gene therapy, and emerging pharmacological targets.
Structure generated from article content
Expand all
Collapse all
AI and Glaucoma Progression
1
Investigational Neuroprotective Agents
6
Gene Therapy Approaches
1
Mitochondrial-Targeted Neuroprotection
1
Metabolic Neuroprotection
1
Clinical Trials
2
Systemic Agents
1
Retinal Ganglion Cell Replacement
1
Vascular Targets for Neuroprotection
1
Nicotinamide Supplementation
1
Novel Neuroprotective Strategies
1
Clinical Trial Design
1
Glaucoma and Neurodegenerative Diseases
1
Investigational Drugs
5
Neuroprotection Strategies
3
Neurodegenerative Links
1
Mechanobiological Studies
1
Drug Repurposing
1
Biomarkers For Neuroprotection
1
Neuroprotective Strategies
6
Drug Discovery
1
Neurotrophic Factors
1
Biomarkers Of Glaucoma
1
Retinopathy Of Prematurity
1
Nutritional Factors
1
Novel Iop-Lowering Agents
1
Rho-Kinase Inhibitors
1
Investigational Antifibrotic Agents
1
Systemic Factors In Glaucoma
1
Mitochondrial-Based Therapies
1
Neurodegenerative Mechanisms
1
Mechanisms Of Neurodegeneration
1
Neuroprotective Mechanisms
1
Novel Therapeutic Targets
2
Ocular And Cerebral Fluid Dynamics
1
Antioxidant Therapies
1
Gene Therapy
1
Systemic Medications
1
Biomarkers For Glaucoma
1
Biomarkers
1
Molecular Mechanisms Of Neuroprotection
1
Neuroprotection Targets
1
Neuroprotective Agents
1